Table 3.
Period | Saline |
Blocker |
||
---|---|---|---|---|
Baseline | Hyperglycemic | Baseline | Hyperglycemic | |
Control epinephrine, pg/ml | 60.3 ± 11.8 | 78.2 ± 19.1 | 75.9 ± 8.7 | 75.2 ± 12.8 |
IUGR epinephrine, pg/ml | 163.5 ± 31.7* | 152.1 ± 52.6 | 1847 ± 856* | 2332 ± 1134* |
Control norepinephrine, pg/ml | 570 ± 86 | 1171 ± 287 | 1090 ± 226 | 1683 ± 444 |
IUGR norepinephrine, pg/ml | 3264 ± 614* | 3518 ± 1084* | 6758 ± 1802* | 11558 ± 3430* |
Values are means ± SE.
Significant differences, P < 0.05, in catecholamine concentrations for Control vs. IUGR fetuses in their respective study periods.